GlassScriptPhysician profile
Marcella N Castillo
NPI 1811682396
$3,059.66
in general payments reported to CMS, 2019-2025
19 companies · $1,028 in 2025
The $1,028 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,295 · 2024: $737 · 2025: $1,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Travel and Lodging: $806 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.41 |
| Travel and Lodging | $805.55 |
| Education | $116.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $1,163.76 | 2023 | Remede System |
| Inspire Medical Systems, INC. | $389.69 | 2023-2025 | Inspire |
| Boston Scientific Corporation | $279.85 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Administration Set |
| Genzyme Corporation | $248.69 | 2025 | |
| Novo Nordisk INC | $230.37 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Electromed, INC. | $172.44 | 2024-2025 | Smartvest |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $89.68 | 2024-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $87.26 | 2024-2025 | Eliquis, Camzyos |
| Grifols USA, LLC | $49.55 | 2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $46.71 | 2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $46.46 | 2025 | Fasenra, Airsupra |
| Merck Sharp & Dohme LLC | $44.50 | 2024 | Verquvo, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.97 | 2024 | Jardiance |
| Mylan Specialty L.P. | $20.65 | 2024 | Yupelri |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.98 | 2024 | Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $17.48 | 2023 | Xarelto |
| Inogen, INC. | $15.68 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Edwards Lifesciences Corporation | $13.95 | 2023 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcella Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.